SS Innovations International Inc. Common Stock (SSII) - Cash Flow Conversion Efficiency
Based on the latest financial reports, SS Innovations International Inc. Common Stock (SSII) has a cash flow conversion efficiency ratio of -0.040x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.52 Million) by net assets ($38.22 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
SS Innovations International Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how SS Innovations International Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read SSII total liabilities for a breakdown of total debt and financial obligations.
SS Innovations International Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SS Innovations International Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Goldcard High-Tech Co Ltd
SHE:300349
|
0.047x |
|
ORIENT SECUR.CO.LTD.H YC1
F:OS9
|
N/A |
|
WESTLIFE FOODWORLD LIMITED
NSE:WESTLIFE
|
0.240x |
|
Metro Healthcare Indonesia
JK:CARE
|
0.005x |
|
G-Shank Enterprise Co Ltd
TW:2476
|
0.034x |
|
Kvutzat Acro Ltd.
TA:ACRO
|
-0.030x |
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
-0.169x |
|
Huawen Media Investment Corp
SHE:000793
|
-0.049x |
Annual Cash Flow Conversion Efficiency for SS Innovations International Inc. Common Stock (2016–2025)
The table below shows the annual cash flow conversion efficiency of SS Innovations International Inc. Common Stock from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see SSII market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $38.22 Million | $-18.54 Million | -0.485x | +31.29% |
| 2024-12-31 | $13.46 Million | $-9.50 Million | -0.706x | +34.27% |
| 2023-12-31 | $14.30 Million | $-15.36 Million | -1.074x | -148.01% |
| 2022-12-31 | $-2.68 Million | $-5.99 Million | 2.238x | +187.12% |
| 2021-12-31 | $141.33K | $-363.03K | -2.569x | -2565.64% |
| 2020-12-31 | $-869.05K | $-90.54K | 0.104x | -73.88% |
| 2019-12-31 | $-1.06 Million | $-424.11K | 0.399x | -72.61% |
| 2018-12-31 | $-304.35K | $-443.29K | 1.457x | +132.95% |
| 2017-12-31 | $101.09K | $-446.86K | -4.420x | -925.02% |
| 2016-12-31 | $-355.06K | $-190.23K | 0.536x | -- |
About SS Innovations International Inc. Common Stock
SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The comp… Read more